Apoptosis and cancer chemotherapy /
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Totowa, N.J. :
Humana Press,
[1999]
|
| Series: | Cancer drug discovery and development ;
5. |
| Subjects: |
Table of Contents:
- Does apoptosis contribute to tumor cell sensitivity to anticancer agents?
- p53, apoptosis and chemotherapy
- The role of p53 in chemosensitivity
- Function of the p53 gene family: a holistic perspective
- Mismatch repair deficiencty, apoptosis, and drug resistance
- Involvement of c-Abl tyrosine kinase in apoptotic response to anticancer agents
- Bcl-2 family proteins: relative importance as determinants fo chemoresistance in cancer
- Bax, a death effector molecule: its role in development and oncogenesis
- Bax, a proapoptotic protein forming channels in mitochondria
- Mechanism of action of the proapoptotic gene Bak
- Killers or clean-up crews: How central are the central mechanisms of apoptosis?
- Role of CD95 (APO-1/Fas) system in chemotherapy
- Insulin-like growth factor-1 receptor as a target for anticancer therapy
- Drug resistance and the survival niche: survival signals combine to suppress drug-induced apoptosis in B-lymphoma cells
- Chemotherapy, tumor microenvironment, and apoptosis
- Molecular regulation and therapeutic implications of cell death in prostate cancer
- Chemotherapy and apoptosis in the ovary: cancer treatment comes with a price
- Role of Bel-2 family members in homeostasis, in toxicology in normal intestine, and for prognosis of colonic carcinomas
- Apoptosis and breast cancer
- Role of apoptosis in human neuroblastomas
- Response of testicular-tumors to chemotherapy: relative role of drug-DNA interactions and apoptosis
- Concluding remarks: Has the information explosion on apoptosis affected clinical practice?